News
A world-first artificial cell can chase chemicals using only a membrane, an enzyme, and a pore—no DNA or motors needed.
Aurinia Pharmaceuticals is a strong investment in 2025 with Q1 growth, profit projections, and expert analysis. Click for my AUPH stock update.
T follicular helper (Tfh) cells are a vital subset of helper T cells that control the formation of germinal centers (GCs) in TLOs and drive the maturation of long‐lived, high‐affinity B cells into ...
Optimizing Allogeneic Chimeric Antigen Receptor T-Cell Persistence in Relapsed/Refractory Large B-Cell Lymphoma: The Role of KIR Matching. If you have the appropriate software installed, you can ...
A research team has discovered a previously unknown mechanism that could explain why many patients with aggressive B-cell lymphoma do not respond to CAR-T cell therapy in the long term. The ...
J. Brown ’s “True Love” charts a successful course to No. 1 on Billboard ’s Adult R&B Airplay radio ranking as it rises from No. 2 to crown the list dated June 21. The song gives Brown his ...
CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic and musculoskeletal diseases (RMD).
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma Provided by PR Newswire Jun 13, 2025, 8:00:00 AM ...
Wayne Lewis, founding member of the platinum-selling R&B group Atlantic Starr, has died. He was 68 years old.
Hosted on MSN1mon
Kendrick Lamar and SZA’s “Luther” breaks R&B/Hip-Hop chart ... - MSN- Kendrick Lamar and SZA's “Luther” set a new record, topping the Hot RandB/Hip-Hop Songs chart for 23 weeks, surpassing Kendrick's “Not Like Us,” highlighting their significant influence ...
Genentech is investigating Columvi as a monotherapy and in combination with other medicines for the treatment of diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma.
7046Background: Treating relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) is challenging despite advances. AZD0486, a novel IgG4 fully human CD19xCD3 bispecific T-cell engager, showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results